AQST241220C10000
- 0.12
- 0.000.00%
Aquestive Therapeutics Newsroom
Aquestive Therapeutics: Promising FDA Feedback and Solid Foundation Support Buy Rating
Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10
Aquestive Therapeutics Announces DA Feedback And Reaffirms NDA Submission Guidance For Anaphylm Sublingual Film; Confirms No Additional Adult Clinical Trials Are Necessary Prior To NDA Submission
Aquestive Therapeutics Gains FDA Support for Anaphylm
Express News | Aquestive Therapeutics Inc -Reaffirms New Drug Application (Nda) Q1 2025 Submission Guidance
Express News | Aquestive Therapeutics Inc -Confirms No Additional Adult Clinical Trials Are Necessary Prior to Nda Submission
Express News | Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms Nda Submission Guidance for Anaphylm™ (Epinephrine) Sublingual Film
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 13% Over the Past Week
US Manufacturing Index Rises To 43, Highest Since 2020
Aquestive Therapeutics: Strong Buy Rating Driven by Robust Revenue Performance and Strategic Positioning in Allergy Treatment
Aquestive Therapeutics Advances Drug Candidates Amid Challenges
Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $10
H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10
Promising Future and Strategic Advancements: Buy Recommendation for Aquestive Therapeutics
Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript Summary
JMP Securities Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9
Buy Rating Affirmed for Aquestive Therapeutics Amid Strong Product Pipeline and Financial Stability
Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Aquestive Therapeutics Optimistic Financial and Strategic Outlook
Aquestive Therapeutics | 10-Q: Q3 2024 Earnings Report